Viking Therapeutics Inc.
VKTX | NASDAQ
$30.11
+$1.12 (+3.86%)
At close: Sep 21, 2026, 4:00 PM ET
$31.80
+$1.69 (+5.61%)
Pre-market:
Sep 22, 2026, 5:08 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -128.02M | -158.33M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M | -14.01M |
Depreciation & Amortization | 157K | -1.21M | 94K | 114K | -5.59M | 111K | 110K | 87K | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | n/a | 77K | 76K | 75K | 73K | 72K |
Stock-Based Compensation | 11.13M | 10.34M | 8.59M | 7.34M | 13.55M | 11.35M | 5.67M | 8.98M | 7.08M | 7.98M | 4.08M | 4.48M | 4.62M | 3.57M | 2.16M | 1.94M | 2.22M | 2.36M | 1.43M | 1.6M | 1.49M | 1.58M |
Other Working Capital | -8.64M | 20.35M | 16.23M | -9.77M | 9.42M | -15.42M | -6.46M | 8.46M | -13.72M | 17.58M | 3.78M | 1.36M | 3.27M | -3.92M | 978K | 2.96M | -1.94M | 641K | -1.47M | 1.09M | -804K | -373K |
Other Non-Cash Items | -1.63M | 1K | -1.79M | -2.02M | 3.34M | -3.1M | -4M | -5.06M | -5.41M | -2.78M | -2.67M | 12K | -1.92M | -349K | -75K | 195K | 511K | 686K | 767K | 939K | 1.07M | 1.16M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.81M | 35.22M | 65.48M | -8.64M | 7.2M | -15.06M | 2.46M | -1.03M | -8.01M | 15.95M | 5.48M | 1.46M | 5.02M | -8.4M | 6.48M | -3K | 1.26M | 2.45M | -2.27M | -296K | -682K | 321K |
Operating Cash Flow | -125.17M | -113.98M | -85.29M | -94M | -47.06M | -52.33M | -31.18M | -21.96M | -28.51M | -6.13M | -17.64M | -19.66M | -11.44M | -24.64M | -10.93M | -13.5M | -13.44M | -10.53M | -12.35M | -10.93M | -13.43M | -10.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -70.05M | -72.44M | -40.49M | -21.45M | -123.48M | -232.61M | -136.96M | -149.99M | -229.82M | -596.6M | -97.53M | -79.4M | -243.98M | -57.4M | -44.61M | -10.45M | -35.7M | -30.68M | -35.57M | -24.17M | -59.6M | -48.68M |
Sales Maturities Of Investments | 179.49M | 936K | 116.11M | 181.48M | -11K | 295.86M | 143.54M | 175.89M | 103.76M | 136.81M | 133.27M | 66.87M | 39.49M | 59.59M | 51.87M | 37.34M | 54.68M | 32.3M | 62.98M | 37.78M | 63.16M | 42.05M |
Other Investing Acitivies | n/a | 125.69M | n/a | n/a | 165.99M | n/a | n/a | n/a | n/a | n/a | n/a | -12.53K | n/a | 2.2K | n/a | 26.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 109.43M | 54.19M | 75.61M | 160.03M | 42.51M | 63.25M | 6.58M | 25.9M | -126.06M | -459.79M | 35.73M | -12.53M | -204.48M | 2.2M | 7.26M | 26.89M | 18.98M | 1.62M | 27.41M | 13.62M | 3.56M | -6.63M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -37K | n/a | n/a | -1.67M | -5.12M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 11.63M | 73.95M | n/a | n/a | n/a | 47.66M | -44.14M | 2.93M | 8.92M | -269.76M | -1.97M | -5.41M | 5.9M | 10.62M | n/a | 84K | -499K | n/a | -234K | n/a | -473K |
Financial Cash Flow | 23.59M | 12.08M | 75.1M | 480K | 507K | 349K | 1M | 2.52M | 2.91M | 606.04M | 188K | -74K | 267.08M | 4.18M | 10.75M | 10K | -1.59M | -5.01M | 47K | -256K | 1.9M | 5.19M |
Net Cash Flow | 7.85M | -47.69M | 65.43M | 66.5M | -4.06M | 11.26M | -23.67M | 6.43M | -151.66M | 140.06M | 18.33M | -32.33M | 51.16M | -18.27M | 7.22M | 13.18M | 3.77M | -13.92M | 15.11M | 2.44M | -7.98M | -12.31M |
Free Cash Flow | -125.17M | -113.98M | -85.29M | -94M | -47.06M | -52.33M | -31.18M | -21.96M | -28.51M | -6.13M | -17.64M | -19.66M | -11.44M | -24.64M | -10.93M | -13.5M | -13.44M | -10.53M | -12.35M | -10.93M | -13.43M | -10.88M |
Adj. Free Cash Flow | -136.31M | -124.31M | -93.88M | -101.34M | -60.61M | -63.68M | -36.85M | -30.94M | -35.6M | -14.12M | -21.72M | -24.14M | -16.06M | -28.21M | -13.08M | -15.44M | -15.66M | -12.89M | -13.78M | -12.53M | -14.93M | -12.45M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -125.17M | -113.98M | -85.29M | -94M | -47.06M | -52.33M | -31.18M | -21.96M | -28.51M | -6.13M | -17.64M | -19.66M | -11.44M | -24.64M | -10.93M | -13.5M | -13.44M | -10.53M | -12.35M | -10.93M | -13.43M | -10.88M |
Add to Watchlist
Select watchlists to add or remove VKTX